Moore Capital Management LP Has $6.61 Million Stake in Teleflex Incorporated $TFX

Moore Capital Management LP lowered its holdings in Teleflex Incorporated (NYSE:TFX) by 50.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,175 shares of the medical technology company’s stock after selling 52,475 shares during the period. Moore Capital Management LP’s holdings in Teleflex were worth $6,614,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Kelleher Financial Advisors bought a new stake in Teleflex during the 2nd quarter worth about $25,000. Banque Cantonale Vaudoise increased its position in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares during the last quarter. UMB Bank n.a. increased its position in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 113 shares during the last quarter. Allworth Financial LP bought a new stake in Teleflex during the second quarter worth about $44,000. Finally, Kestra Advisory Services LLC bought a new stake in Teleflex during the fourth quarter worth about $45,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Up 0.1%

Shares of NYSE:TFX opened at $139.81 on Monday. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $145.00. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The company has a market capitalization of $5.92 billion, a P/E ratio of -6.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.81. The company has a 50-day simple moving average of $133.86 and a 200 day simple moving average of $126.05.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. The firm had revenue of $570.33 million for the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The business’s revenue was up 28.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s payout ratio is currently -5.84%.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Truist Financial raised their price target on Teleflex from $143.00 to $150.00 and gave the company a “hold” rating in a research note on Monday, August 10th. Wall Street Zen upgraded Teleflex from a “sell” rating to a “hold” rating in a research note on Sunday, August 9th. BMO Capital Markets initiated coverage on Teleflex in a report on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price objective for the company. Raymond James Financial reissued an “outperform” rating and issued a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. Finally, UBS Group raised their target price on shares of Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Teleflex currently has a consensus rating of “Hold” and a consensus target price of $152.90.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.